Seeking Alpha

jjjorgen

jjjorgen
Send Message
View as an RSS Feed
View jjjorgen's Comments BY TICKER:
Latest comments  |  Highest rated
  • 5 Profitable Healthcare Stocks Preferred By Analysts [View article]
    Sorry to see you move on Sky. Take a look at AVEO, I'm expecting a ride back to $12/shr pretty quickly. All on my own dd, of course. I'm heavy into QCOR, and plan on staying that way until Sept 9th, when scrips come out for August. If numbers meet, or beat, expectations, I stay long. That will verify to me we are on our way to $4.00/EPS in 2013. At $60/shr, that would only be a 15 pe. Best of luck trading Sky, hope the chart reading works out for you!
    Aug 19 02:32 PM | 2 Likes Like |Link to Comment
  • Why Buying iBio Makes Good Sense [View article]
    BioMed Reports is a pumping rag. No way I care about what they say.

    http://bit.ly/POETw0
    Jul 26 09:11 PM | 2 Likes Like |Link to Comment
  • Spectrum Could Sink On Aqaziquone Failure [View article]
    It's going to be a good week for Spectrum! Index Funds buying to meet addition into S&P's smallcap index, and record earnings are forthcoming on Thursday. Income Hunter will become Income Loser!
    Hope to see some Short suffering Thursday and Friday.
    Apr 22 11:55 AM | 2 Likes Like |Link to Comment
  • 4 Long And Short Trades You Can Make Monday Morning [View article]
    They are nothing like Computer or Circuit City. Those dopes couldn't figure anything out. Muehlbauer states positive direction in the following comments going away from big box. Change is not immediate in this type of situation, but they are adapting!

    http://seekingalpha.co...
    Apr 2 09:10 AM | 2 Likes Like |Link to Comment
  • Amicus Therapeutics - Long Opportunity With Asymmetric Upside Potential And Near-Term Catalyst [View article]
    Not a bad article for a first SA article! I'm Long, thanks for the write-up!
    Jun 27 11:00 AM | 1 Like Like |Link to Comment
  • Notes From One-On-One Meetings During San Fran Biotech Week - Day 3 [View article]
    Thoughts on CYNAF now?
    Apr 9 04:48 PM | 1 Like Like |Link to Comment
  • Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease [View article]
    Happy for you, Mane, now load up on shares!
    Apr 9 09:52 AM | 1 Like Like |Link to Comment
  • How MannKind Shows Depth Of The Diabetes Market [View article]
    The replies here are 1000 times better than the article! Partnership or sale of the company soon, it's just a given!
    Apr 4 09:20 AM | 1 Like Like |Link to Comment
  • A Comprehensive Look At Athersys [View article]
    11137741~ Nice rebuttal! Looking forward to Thursday afternoon's call!
    Mar 9 05:15 PM | 1 Like Like |Link to Comment
  • A Picture Is Worth A Thousand Words: Implications From Sovaldi Treatment Trends [View article]
    Thanks!! Great write up!
    Feb 24 04:54 PM | 1 Like Like |Link to Comment
  • Athersys: Why Did Shareholders Come Knocking At The Door Once Again? [View article]
    WST, thanks for speaking up to Northwest Investor. His concerns and flags go for most bios out there. I for one, want to invest in these companies on the ground floor. The high quality ones normally get bought up before ever becoming a drug selling company. If Phase 2 trials show success, wouldn't you think someone like Pfizer wouldn't just buy Athersys for $10/share, to reap the potential future blowout rewards? How about Intercept? Us investors all dream of something like this happening. We're out there looking and researching for the best bets in future returns. I think Northwest is best buying into a great ETF like BBH, and leave us who want to take a little risk, to our investing.
    Jan 16 08:50 AM | 1 Like Like |Link to Comment
  • Aeterna Zentaris spikes as FDA accepts NDA for filing [View news story]
    Pathetic management in place for this company. Over a year late on this NDA. Drug may be worth $2 million a year in sales. Sell on the slight rise.
    Jan 6 02:01 PM | 1 Like Like |Link to Comment
  • Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way [View article]
    WST~ Couldn't have said it better. I know those of us who have researched the heck out of this company get tired of defending it, but one day we'll be able to say, Told you so! I'm to the point of not saying anything, as 2014 will speak for itself. Glad you're on the right side of the argument!
    Jan 6 09:51 AM | 1 Like Like |Link to Comment
  • Athersys, Inc.: '2014' [View article]
    WST~ Saw it, great article!! Thanks, looking forward to 2014!
    Nov 23 01:07 PM | 1 Like Like |Link to Comment
  • Athersys, Inc.: '2014' [View article]
    I love this statement from Gil:
    Recently, we conducted a trial investigator meeting to review study progress in key aspects of the trial with the clinicians and study site coordinators. During the meeting, leading clinicians from a couple of the highest-enrolling sites shared their experience with the other study site investigators and site coordinators, and it's fair to say there was a lot of excitement at the meeting. Our enthusiasm for the study remains very high. We believe that this approach has tremendous potential and could represent a major advance in stroke clinical care.

    In the U.S., enrollment continues to ramp up as we build momentum, with enrollment rates improving with the addition of new sites and increased site activity levels and impact of recent minor protocol amendments.

    Momentum has also been building in Europe. In August, we received formal ethics approval to initiate the trial in the U.K. And since that time, we have conducted site training and have been completing certain logistical activities, such as finalizing site contracts. This process has taken a bit longer than we had hoped, but the initial U.K. sites are now in the process of launching. We expect 4 sites to be operational in the next few weeks, with 2 more added early next year.

    Given that these sites tend to see a larger number of stroke patients than many of the sites in the U.S., we anticipate that this will continue to drive momentum for the study. Our objective is the disclosure of the initial results from the study sometime next summer
    Nov 23 10:38 AM | 1 Like Like |Link to Comment
COMMENTS STATS
311 Comments
200 Likes